Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predicting who will need ICU care after cancer surgery

Official title: Comparison of ASA, SORT, CACI, and P-POSSUM Scores for Predicting Postoperative Intensive Care Unit Requirement in Patients Undergoing Oncologic Surgery

Run by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · NCT07542925 · Data updated 2026-11-12

This study will test common risk scores to see if they can predict which adult cancer surgery patients will need ICU care after their operation.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedSeptember 15, 2026
Study endsNovember 15, 2026
Registry record updatedApril 21, 2026
Trial IDNCT07542925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) scheduled for elective or emergency oncologic surgery at the enrolling center who can provide written informed consent are the intended participants.

Probably not a fit

Patients already requiring continuous ICU care before the current surgery, pediatric patients under 18, or those treated outside the enrolling center are unlikely to receive direct benefit from this study's predictions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort will enroll 500 adult patients undergoing elective or emergency oncologic surgery at a single tertiary oncology center. Investigators will record preoperative demographics and clinical data, intraoperative variables, and perioperative factors using a standardized form and capture functional and nutritional measures such as ECOG, NRS-2002, and preoperative serum albumin. Several perioperative risk scores (ASA, SORT, age-adjusted CACI, and P-POSSUM) will be calculated and their performance for predicting planned and unplanned postoperative ICU admission compared using discrimination and calibration metrics. Findings aim to identify which instruments best predict ICU requirement to inform perioperative planning and critical-care resource allocation.

Why it matters

Potential benefit: If successful, clinicians could more accurately identify patients who need postoperative ICU care, improving patient safety and helping hospitals allocate critical care beds more efficiently.

How similar studies have gone: While ASA, SORT, Charlson indices and P-POSSUM have been used to predict surgical risk and outcomes, prospective head-to-head comparisons specifically for postoperative ICU requirement in oncologic populations are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years and older.
* Patients scheduled for elective or emergency oncologic surgery.
* Patients who are able to provide written informed consent.
* Patients whose data will be analyzed for both planned and unplanned intensive care unit (ICU) admissions.

Exclusion Criteria:

* Patients under 18 years of age.
* Patients requiring continuous ICU follow-up due to a pre-existing critical illness prior to the current surgery.
* Patients who do not provide consent to participate in the study.

Where it's running

  • Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.